Novartis Pharma AG,   Switzerland

Eye drops 1%.

Solution for infusions 5 mg / 100 ml.

Tablets of 2.5 mg.

The film-coated tablets are 200 mg and 400 mg.

Tablets, 50 mg.

Capsules, 0.5 mg.

Tablets, 10 mg.

Concentrate for the preparation of a solution for infusions of 4 mg / 5 ml.

Solution for infusion 4 mg / 100 ml.

Solution for intravenous and intramuscular injection, 2 mg / ml.

Lyophilizate for the preparation of a solution for subcutaneous administration, 150 mg.

Tablets, film-coated, 80 mg + 12.5 mg, 160 mg + 12.5 mg, 160 mg + 25 mg, 320 mg + 12.5 mg and 320 mg + 25 mg.

Tablets, film-coated, 5 mg + 160 mg + 12.5 mg, 10 mg + 160 mg + 12.5 mg.

Lyophilizate for the preparation of a solution for subcutaneous administration, 150 mg, complete with a solvent - water for injection.

Lyophilizate for the preparation of a solution for infusions, 350 mg and 500 mg.

Solution for intraocular administration with ranibizumab 10 mg / ml.

1. To 0.23 ml in a bottle of colorless glass, corked with a rubber stopper, coated with an aluminum cap with a snap-off lid.

By one a vial complete with a needle equipped with a filter to extract the contents from the vial, a syringe, an injection needle along with an instruction for medical application in a cardboard box.

1. For 0.165 ml of the drug in pre-filled glass syringe, sealed with a rubber stopper with a white polypropylene cover to control the first opening. One by one in advance filled syringe in a blister equipped with a label, along with instructions for medical use in a cardboard box.

Eye drops 0.5%; 1%.

Capsules with powder for inhalation, 150 mcg and 300 mcg.

Lyophilizate for the preparation of a solution for subcutaneous and intravenous administration of 18 million IU / ml in a vial.

Film-coated tablets, 25 mg and 50 mg.

Concentrate for the preparation of a solution for infusions of 50 mg / ml, 1 ml in ampoules.

Solution for intravenous and subcutaneous administration, 0.05 mg / ml, 0.1 mg / ml and 0.5 mg / ml.

Microspheres for suspension for intramuscular administration, 10 mg, 20 mg and 30 mg.

Capsules with powder for inhalation, 50 mcg.

Solution for subcutaneous administration 0.3 mg / ml, 0.6 mg / ml and 0.9 mg / ml.

1 ml each in ampoules from colorless glass, the ampoule has a broken point. 6

ampoules are placed into the paper with instructions for use in

cardboard tutu.

Multi-pack. 3, 5 or 10 packs of 6 ampoules.

Drops of the eye 0.5 mg + 0.4 mg / ml.

Tablets coated with 60 mg, 120 mg, 180 mg

12 tablets in a blister pack. 1, 2, 5, 7, 10 or 30 blisters with instructions for use in a cardboard bundle.

Capsules 0.5 mg, 1 mg, 5 mg.

10 capsules per blister of PVC / PE / PVDC / aluminum. By 5, 6, 9

or 10 blisters are placed in a bag (aluminum / aluminum) containing Desiccant with the inscription: "Not there is! ". For 1 package together with instruction on medical application is placed in cardboard pack.

Capsules 150 mg and 200 mg.

A set of capsules and film-coated tablets, 50 mg and 0.5 mg, 50 mg and 2.0 mg, 75 mg and 0.5 mg, 75 mg and 2.0 mg.

Tablets 200 mg, 400 mg.

Tablets of prolonged action, coated with a coating, 200 mg and 400 mg.

Tablets, film-coated, 150 mg, 300 mg, 600 mg.

Suspension for oral administration, 60 mg / ml.

Capsules with powder for inhalation 50 μg + 110 μg.

Tablets coated with a coating, 125 mg, 250 mg, 500 mg.

Capsules, 10 mg, 15 mg and 20 mg.

Capsule with powder for inhalation set.

Film-coated tablets, 5 mg / 80 mg, 5 mg / 160 mg or 10 mg / 160 mg.

Film-coated tablets, 50 mg (25.7 mg + 24.3 mg); 100 mg (51.4 mg + 48.6 mg); 200 mg (102.8 mg + 97.2 mg).